Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this …

What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Introduction Acinetobacter baumannii antimicrobial resistance is a public health concern in
developing and developed countries, especially in the hospital setting. Understanding the …

INTRODUCTION: The increase in the prevalence of multidrug-resistant Acinetobacter
baumannii infections in hospital settings has rapidly emerged worldwide as a serious health …

Healthcare-associated infections (HAIs) occurring in patients treated in an intensive care
unit (ICU) are serious complications in the treatment process. Aetiological factors of these …

Acinetobacter baumannii is an important pathogen in clinical. The factors of biofilm
formation, antibiotic resistance and motility contribute great to A. baumannii in persisting in …

Background The problem of inappropriate use of antibiotics and the resulting growth in
antimicrobial resistance (AMR) has implications for Poland and the world. The objective of …

Antibiotic resistance is a growing problem worldwide. The emergence and rapid spread of
antibiotic resistance determinants have led to an increasing concern about the potential …

Purpose. Nosocomial infections caused by multidrug resistant Acinetobacter baumannii
have emerged as a serious problem in healthcare settings worldwide. Methodology. A total …

Intravenous (iv) minocycline is increasingly used to treat infections caused by multidrug-
resistant (MDR) Acinetobacter baumannii. Despite its being approved nearly 50 years ago …